>
GURUFOCUS.COM > STOCK LIST > Healthcare > Drug Manufacturers > Bristol-Myers Squibb Co (NYSE:BMY) > Definitions > GF Value Rank
Switch to:

Bristol-Myers Squibb Co GF Value Rank

: 5 (As of Today)
View and export this data going back to 1952. Start your Free Trial

Bristol-Myers Squibb Co has the GF Value Rank of 5.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Bristol-Myers Squibb Co GF Value Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's GF Value Rank falls into.



Bristol-Myers Squibb Co GF Value Rank Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Bristol-Myers Squibb Co logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Executives
Vousden Karen H director 345 PARK AVENUE NEW YORK NY 10154
Samuels Theodore R. Ii director 1990 E. GRAND AVE. EL SEGUNDO CA 90245
Haller Julia A director C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Paliwal Dinesh C director 5454 W 110TH STREET OVERLAND PARK KS 66211
Rice Derica W director LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Emmens Matthew director C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Bertolini Robert J director C/O SCHERING PLOUGH CORP 2000 GALLOPING HILL RD KENILWORTH NJ 070333
Price Paula A director ONE CVS DRIVE WOONSOCKET RI 02895
Yale Phyllis R director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: YALE PHYLLIS R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Bonney Michael W director 65 HAYDEN AVE LEXINGTON MA 02421
Arduini Peter J director 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Santiago Karen Murphy officer: SVP & Controller BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCE LINE ROAD PRINCETON NJ 08540
Caforio Giovanni director, officer: Chairman and CEO BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCELINE ROAD LAWRENCEVILLE NJ 08543
Eid Joseph officer: SVP,Head Glob. Medical Affairs BRISTOL-MYERS SQUIBB COMPANY 3401 PRINCETON PIKE LAWRENCEVILLE NJ 08648
Leung Sandra officer: EVP, General Counsel C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164

Bristol-Myers Squibb Co Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)